BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27671309)

  • 1. Evaluation of Melatonin Effect on Human Breast Cancer Stem Cells Using a Threedimensional Growth Method of Mammospheres.
    Lopes JR; da Silva Kavagutti M; de Medeiros FAF; de Campos Zuccari DAP
    Anticancer Agents Med Chem; 2017; 17(7):961-965. PubMed ID: 27671309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines.
    Gonçalves Ndo N; Colombo J; Lopes JR; Gelaleti GB; Moschetta MG; Sonehara NM; Hellmén E; Zanon Cde F; Oliani SM; Zuccari DA
    PLoS One; 2016; 11(3):e0150407. PubMed ID: 26934679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
    Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro].
    Peng L; Li FX; Shao WF; Xiong JB
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1421-6. PubMed ID: 24144739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin represses self-renewal of the human breast carcinoma stem cells via inhibition of estrogen receptor-mediated OCT4 expression.
    Jung JW; Park SB; Lee SJ; Seo MS; Trosko JE; Kang KS
    PLoS One; 2011; 6(11):e28068. PubMed ID: 22132214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.
    Wahler J; So JY; Cheng LC; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():148-55. PubMed ID: 25445919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A trans-platinum(II) complex induces apoptosis in cancer stem cells of breast cancer.
    Aztopal N; Karakas D; Cevatemre B; Ari F; Icsel C; Daidone MG; Ulukaya E
    Bioorg Med Chem; 2017 Jan; 25(1):269-276. PubMed ID: 27839660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the stemness potency of
    Yousefnia S; Ghaedi K; Seyed Forootan F; Nasr Esfahani MH
    Tumour Biol; 2019 Aug; 41(8):1010428319869101. PubMed ID: 31423948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway.
    An H; Kim JY; Lee N; Cho Y; Oh E; Seo JH
    Biochem Biophys Res Commun; 2015 Oct; 466(4):696-703. PubMed ID: 26407842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
    Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
    Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrially targeted vitamin E succinate efficiently kills breast tumour-initiating cells in a complex II-dependent manner.
    Yan B; Stantic M; Zobalova R; Bezawork-Geleta A; Stapelberg M; Stursa J; Prokopova K; Dong L; Neuzil J
    BMC Cancer; 2015 May; 15():401. PubMed ID: 25967547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2-positive cancer cells and cancer stem cells.
    Oak PS; Kopp F; Thakur C; Ellwart JW; Rapp UR; Ullrich A; Wagner E; Knyazev P; Roidl A
    Int J Cancer; 2012 Dec; 131(12):2808-19. PubMed ID: 22511343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.
    Ahmadipour F; Noordin MI; Mohan S; Arya A; Paydar M; Looi CY; Keong YS; Siyamak EN; Fani S; Firoozi M; Yong CL; Sukari MA; Kamalidehghan B
    Drug Des Devel Ther; 2015; 9():1193-208. PubMed ID: 25759564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin decreases estrogen receptor binding to estrogen response elements sites on the OCT4 gene in human breast cancer stem cells.
    Lopes J; Arnosti D; Trosko JE; Tai MH; Zuccari D
    Genes Cancer; 2016 May; 7(5-6):209-17. PubMed ID: 27551335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
    Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
    BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression.
    Borin TF; Arbab AS; Gelaleti GB; Ferreira LC; Moschetta MG; Jardim-Perassi BV; Iskander AS; Varma NR; Shankar A; Coimbra VB; Fabri VA; de Oliveira JG; Zuccari DA
    J Pineal Res; 2016 Jan; 60(1):3-15. PubMed ID: 26292662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition.
    Lamb R; Harrison H; Hulit J; Smith DL; Lisanti MP; Sotgia F
    Oncotarget; 2014 Nov; 5(22):11029-37. PubMed ID: 25415228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.
    Hou ZJ; Luo X; Zhang W; Peng F; Cui B; Wu SJ; Zheng FM; Xu J; Xu LZ; Long ZJ; Wang XT; Li GH; Wan XY; Yang YL; Liu Q
    Oncotarget; 2015 Mar; 6(8):6326-40. PubMed ID: 25811972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monobenzyltin Complex C1 Induces Apoptosis in MCF-7 Breast Cancer Cells through the Intrinsic Signaling Pathway and through the Targeting of MCF-7-Derived Breast Cancer Stem Cells via the Wnt/β-Catenin Signaling Pathway.
    Fani S; Dehghan F; Karimian H; Mun Lo K; Ebrahimi Nigjeh S; Swee Keong Y; Soori R; May Chow K; Kamalidehghan B; Mohd Ali H; Mohd Hashim N
    PLoS One; 2016; 11(8):e0160836. PubMed ID: 27529753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs.
    Ji P; Zhang Y; Wang SJ; Ge HL; Zhao GP; Xu YC; Wang Y
    Oncol Rep; 2016 Jun; 35(6):3293-302. PubMed ID: 27109463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.